DOOR (deafness, onychodystrophy, osteodystrophy, and mental retardation) syndrome is a genetic disease which is inherited in an autosomal recessive fashion. DOOR syndrome is characterized by mental retardation, sensorineural deafness, abnormal nails and phalanges of the hands and feet, and variable seizures. A similar deafness-onychodystrophy syndrome is transmitted as an autosomal dominant trait and has no mental retardation. Some authors have proposed that it may be the same as Eronen Syndrome, but since both disorders are extremely rare it is hard to make a determination.[1]
| DOOR syndrome | |
|---|---|
| Other names | Deafness-onychodystrophy-osteodystrophy-intellectual disability-seizures syndrome |
 | |
| This condition is inherited in an autosomal recessive manner | |
| Specialty | DiseasesDB = 32494 |
Signs and symptoms
editThis section is empty. You can help by adding to it. (June 2024) |
Cause
editThe recurrence of DOOR in siblings and the finding of DOOR syndrome in a few families with consanguinity suggest that the condition is an autosomal recessive genetic condition. Mutations in TBC1D24 have been identified in 9 families.[2]
Diagnosis
editThis section is empty. You can help by adding to it. (August 2017) |
Treatment
editThis section is empty. You can help by adding to it. (August 2017) |
References
edit- ^ Le Merrer M, David A, Goutieres F, Briard ML (October 1992). "Digito-reno-cerebral syndrome: confirmation of Eronen syndrome". Clin. Genet. 42 (4): 196–8. doi:10.1111/j.1399-0004.1992.tb03236.x. PMID 1424243. S2CID 28902508.
- ^ Campeau, P. M.; Kasperaviciute, D.; Lu, J. T.; Burrage, L. C.; Kim, C.; Hori, M.; Powell, B. R.; Stewart, F.; Félix, T. M. M.; Van Den Ende, J.; Wisniewska, M.; Kayserili, H. L.; Rump, P.; Nampoothiri, S.; Aftimos, S.; Mey, A.; Nair, L. D. V.; Begleiter, M. L.; De Bie, I.; Meenakshi, G.; Murray, M. L.; Repetto, G. M.; Golabi, M.; Blair, E.; Male, A.; Giuliano, F.; Kariminejad, A.; Newman, W. G.; Bhaskar, S. S.; Dickerson, J. E. (2014). "The genetic basis of DOORS syndrome: An exome-sequencing study". The Lancet Neurology. 13 (1): 44–58. doi:10.1016/S1474-4422(13)70265-5. PMC 3895324. PMID 24291220.